Skip to main content

Table 1 Clinicopathological features at operation

From: A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer

 

EMR + en bloc

TUR

P value

n = 39

n = 31

Gender

  

0.591

 Male

24 (61.5)

21 (67.7)

 

 Female

15 (38.5)

10 (32.3)

 

Tumour

  

0.148

 Primary

36 (92.3)

25 (80.6)

 

 Recurrent

3 (7.7)

6 (19.4)

 

Location of main tumour

  

0.879

 Lateral

14 (35.9)

13 (41.9)

 

 Posterior

13 (33.3)

9 (29.0)

 

 Dome

7 (17.9)

4 (12.9)

 

 Trigone

5 (12.8)

5 (16.1)

 

Pathological grade

  

0.896

 Grade 1

12 (30.8)

10 (32.3)

 

 Grade 2

19 (48.7)

16 (51.6)

 

 Grade 3

8 (20.5)

5 (16.1)

 

Pathological T stage

  

0.915

 Ta

19 (48.7)

16 (51.6)

 

 T1

18 (46.2)

14 (45.2)

 

 T2

2 (5.1)

1 (3.2)

 
  1. EMR endoscopic mucosal resection, TUR transurethral resection